Exicure has concluded subject enrolment in its ongoing randomised Phase II trial on GPC-100 (burixafor) in conjunction with ...

an oral small molecule that targets colony stimulating factor 1 receptor, KIT proto-oncogene receptor tyrosine kinase, and FMS-like tyrosine kinase 3 harboring an internal tandem duplication ...

0% RR in pts who did not receive sargramostim as adjuvant Cohort II: 12 pts had decrease in PSA (median decline, 32%); 1 pt had >99 ... macrophage colony-stimulating factor; BCG = bacillus ...

Purpose. The efficacy and safety of granulocyte colony-stimulating factor (G-CSF) in critically ill patients with severe sepsis or septic shock were evaluated. Summary. The medical literature was ...

Niktimvo, an anti-colony stimulating factor 1 receptor (CSF-1R) antibody, has received approval in the US for treating chronic GVHD in adult and paediatric patients weighing a minimum of 40kg ...

Emactuzumab, a humanized immunoglobulin G1 monoclonal antibody, targets the CSF-1 receptor and inhibits macrophages in tumor tissue.

caused by excessive colony stimulating factor-1 (CSF-1) protein production. Emactuzumab is a humanized immunoglobulin G1 monoclonal antibody that targets the CSF-1 receptor and inhibits macrophage ...